Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 16;9(1):699.
doi: 10.1038/s41467-018-03164-5.

Physical basis of amyloid fibril polymorphism

Affiliations

Physical basis of amyloid fibril polymorphism

William Close et al. Nat Commun. .

Abstract

Polymorphism is a key feature of amyloid fibril structures but it remains challenging to explain these variations for a particular sample. Here, we report electron cryomicroscopy-based reconstructions from different fibril morphologies formed by a peptide fragment from an amyloidogenic immunoglobulin light chain. The observed fibril morphologies vary in the number and cross-sectional arrangement of a structurally conserved building block. A comparison with the theoretically possible constellations reveals the experimentally observed spectrum of fibril morphologies to be governed by opposing sets of forces that primarily arise from the β-sheet twist, as well as peptide-peptide interactions within the fibril cross-section. Our results provide a framework for rationalizing and predicting the structure and polymorphism of cross-β fibrils, and suggest that a small number of physical parameters control the observed fibril architectures.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

Figures

Fig. 1
Fig. 1
Structural polymorphism of AL1 peptide fibrils. a Side view of reconstructions of fibril morphologies I–X (scale bar, 50 nm). b Cross-sectional slices of the reconstructed densities superimposed with a lattice of parallelograms (red). Reconstructions of morphologies I–V were filtered to 10 Å and morphologies VI–X to a resolution corresponding to their FSC values at 0.143 (scale bar, 5 nm). c Aligned and averaged parallelograms of morphologies I–V sharing a quasi-twofold symmetry. The data from morphology I were included as published (scale bar, 2 nm)
Fig. 2
Fig. 2
Protomer conformation revealed by ss-NMR. a The 2D 13C–13C proton-driven spin diffusion spectrum shows the cross-peaks between aliphatic carbon atoms. b Backbone model of the cross-β sheet implementing Φ/Ψ angles as predicted by the program TALOS+ (scale bar, 1 nm). c Averaged parallelograms of morphologies I–V (gray) superimposed with a peptide dimer (green, magenta) as obtained by NMR. The placement of the peptides followed the considerations described previously for morphology I8 (scale bar, 1 nm). d Side view and top view of a six-layer stack illustrating the structure of a PF. Side-chain conformations were not determined by experiments and represent only conformations that are compatible with the packing shown here
Fig. 3
Fig. 3
Peptide assembly of fibril morphologies I to V. a Side-by-side presentation of the experimentally obtained density and of the peptide assembly of fibril morphologies I to V (scale bar, 10 nm). b Peptide cross-sections showing an exposed N terminus (magenta) and those not exposed (green) within one peptide layer, superimposed with reconstructions (gray) and filtered to 10 Å. Side-chain conformations were not determined by experiments and represent only conformations that are compatible with the packing shown here. The 3D map of morphology I was included as published (scale bar, 2 nm)
Fig. 4
Fig. 4
Mathematical analysis of the observed and theorized fibril morphologies. a Graphical representation of the definition of the parameters nl, ns, and ne for a given fibril cross-section. b Plot of E for all theorized fibril morphologies or cross-sections (blue) vs. n as obtained by the even fit (gray columns). Hence, only white columns have predictive power for the even fit. Red symbols: experimentally observed fibril morphologies. c Close-up of b. Black horizontal division markers show the 1% cutoff of the most stable morphologies for each n value

References

    1. Riek R, Eisenberg DS. The activities of amyloids from a structural perspective. Nature. 2016;539:227–235. doi: 10.1038/nature20416. - DOI - PubMed
    1. Sipe JD, et al. Amyloid fibril proteins and amyloidosis: Chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines. Amyloid. 2016;23:209–213. doi: 10.1080/13506129.2016.1257986. - DOI - PubMed
    1. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006;75:333–366. doi: 10.1146/annurev.biochem.75.101304.123901. - DOI - PubMed
    1. Cherny I, Gazit E. Amyloids: not only pathological agents but also ordered nanomaterials. Angew. Chem. Int. Ed.Engl. 2008;47:4062–4069. doi: 10.1002/anie.200703133. - DOI - PubMed
    1. Sunde M, et al. Common core structure of amyloid fibrils by synchrotron x-ray diffraction. J. Mol. Biol. 1997;273:729–739. doi: 10.1006/jmbi.1997.1348. - DOI - PubMed

Publication types

MeSH terms